Back to Search Start Over

Medivir reports positive results for MIV-210

Source :
M2 Europharma. Oct 7, 2002
Publication Year :
2002

Abstract

M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD Swedish pharmaceutical research and development firm Medivir AB has revealed positive preclinical results for its HIV and hepatitis B antiviral MIV-210. The preclinical studies aimed [...]

Subjects

Subjects :
Medivir AB -- Product information
Pharmaceutical industry -- Testing
Antiviral agents -- Testing
Business
Business, international
Pharmaceuticals and cosmetics industries

Details

Database :
Gale General OneFile
Journal :
M2 Europharma
Publication Type :
News
Accession number :
edsgcl.92517810

Tools

Authors Abstract Subjects Details